Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

The Latest Pharma Jobs, News and Events

pharmiweb.com today | 23 August 2014

ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC

ViaCyte, Inc., a privately held regenerative medicine company announced today that it has entered into a Rights Agreement with Janssen Research & Development LLC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.  The agreement provides Janssen with a future right to evaluate a transaction related to the VC-01™ combination product that ViaCyte is developing for type 1 diabetes. This right will continue through the initial evaluation of clinical efficacy of VC-01.  ViaCyte received $20 million from Janssen and Johnson & Johnson Development Corporation (JJDC).  The payment included a rights fee and a note convertible into equity at a later date.  JJDC has been a long-standing investor in ViaCyte....

“These important transactions provide us with additional resources we need to pursue the further development of the VC-01 product candidate as a potential new treatment option for patients with type 1 diabetes,” said Paul Laikind, Ph.D., President and Chief Executive Officer of ViaCyte.  “We are pleased to be extending our relationship with Janssen and JJDC in this area of mutual interest.”

show more

Latest Poll

Would you ever take part in a Clinical Trial?

Advertising

Content

PharmiWeb.com is a product of PharmiWeb Solutions - a global provider of digital solutions for the pharmaceutical sector.

We increase engagement with healthcare professionals, patients, carers and consumers, through:

Click here to go to learn more about us.

Pharmiweb Solutions